Doxorubicin-loaded PEG-PCL-PEG micelle using xenograft model of nude mice: Effect of multiple administration of micelle on the suppression of human breast cancer

Cancers

Volumn 3, Issue 1, 2011, Pages 61-78

  Cuong, Nguyen Van ^a,b   Jiang, Jian Lin ^a   Li, Yu Lun ^a   Chen, Jim Ray ^c,d   Jwo, Shyh Chuan ^c,d   Hsieh, Ming Fa ^a  

^a CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

^b INDUSTRIAL UNIVERSITY OF HO CHI MINH CITY   (Viet Nam)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Antitumor activity; Biodistribution; Drug delivery system; Monomethoxy poly(ethylene glycol); Nanoparticles; Poly(e caprolactone); Safety evaluation

Indexed keywords

COPOLYMER; DOXORUBICIN; ETHYLENE GLYCOL EPSILON CAPROLACTONE ETHYLENE GLYCOL COPOLYMER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOCOMPATIBILITY; BREAST CANCER; CANCER INHIBITION; CONTROLLED STUDY; CYTOTOXICITY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG DOSAGE FORM COMPARISON; ENDOCYTOSIS; FEMALE; HUMAN; HUMAN CELL; MOUSE; NANOENCAPSULATION; NONHUMAN; PHYSICAL CHEMISTRY; SINGLE DRUG DOSE; TUMOR XENOGRAFT;

EID: 79953715989     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers3010061     Document Type: Article

References (38)

1. Rivera, E.; Valero, V.; Arun, B.; Royce, M.; Adinin, R.; Hoelzer, K.; Walters, R.; Wade, J.L., III; Pusztai, L.; Hortobagyi, G.N. Phase ii study of pegylated liposomal doxorubicin in combination with gemcitabine in patients with metastatic breast cancer. J. Clin. Oncol. 2003, 21, 3249-3254.
2. Shah, J.J.; Orlowski, R.Z.; Thomas, S.K. Role of combination bortezomib and pegylated liposomal doxorubicin in the management of relapsed and/or refractory multiple myeloma. Therapeut. Clin. Risk Manag. 2009, 5, 151-159.
3. Swenson, C.E.; Bolcsak, L.E.; Batist, G.; Guthrie, T.H.J.; Tkaczuk, K.H.; Boxenbaum, H.; Welles, L.; Chow, S.C.; Bhamra, R.; Chaikin, P. Pharmacokinetics of doxorubicin administered i.v. As myocet (tlc d-99; liposome-encapsulated doxorubicin citrate) compared with conventional doxorubicin when given in combination with cyclophosphamide in patients with metastatic breast cancer. Anti-Cancer Drugs 2003, 14, 239-246.
4. Cuong, N.V.; Hsieh, M.F. Recent advances in pharmacokinetics of polymeric excipients used in nanosized anti-cancer drugs. Curr. Drug Metab. 2009, 10, 842-850.
5. Wong, H.L.; Bendayan, R.; Rauth, A.M.; Xue, H.Y.; Babakhanian, K.; Wu, X.Y. A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system. J. Pharmacol. Exp. Ther. 2006, 317, 1372-1381.
6. Xiong, X.-B.; Ma, Z.; Lai, R.; Lavasanifar, A. The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin. Biomaterials 2010, 31, 757-768.
7. Marchi, N.; Hallene, K.; Kight, K.; Cucullo, L.; Moddel, G.; Bingaman, W.; Dini, G.; Vezzani, A.; Janigro, D. Significance of mdr1 and multiple drug resistance in refractory human epileptic brain. BMC Medicine 2004, 2, 37.
8. Zhang, Z.; Huey Lee, S.; Feng, S.S. Folate-decorated poly(lactide-co-glycolide)-vitamine tpgs nanoparticles for targeted drug delivery. Biomaterials 2007, 28, 1889-1899.
9. Sharma, A.K.; Zhang, L.; Li, S.; Kelly, D.L.; Alakhov, V.Y.; Batrakova, E.V.; Kabanov, A.V. Prevention of mdr development in leukemia cells by micelle-forming polymeric surf actant. J. Contr. Release 2008, 131, 220-227.
10. Kim, D.; Lee, E.S.; Oh, K.T.; Gao, Z.G.; Bae, Y.H. Doxorubicin-loaded polymeric micelle overcomes multidrug resistance of cancer by double-targeting folate receptor and early endosomal ph. Small 2008, 4, 2043-2050.
11. Jabr-Milane, L.S.; van Vlerken, L.E.; Yadav, S.; Amiji, M.M. Multi-functional nanocarriers to overcome tumor drug resistance. Cancer Treat. Rev. 2008, 34, 592-602.
12. Blanco, E.; Kessinger, C.W.; Sumer, B.D.; Gao, J. Multifunctional micellar nanomedicine for cancer therapy. Exp. Biol. Med. 2009, 234, 123-131.
13. Torchilin, V.P. Multifunctional nanocarriers. Adv. Drug Deliv. Rev. 2006, 58, 1532-1555.
14. Maeda, H.; Wu, J.; Sawa, T.; Matsumura, Y.; Hori, K. Tumor vascular permeability and the epr effect in macromolecular therapeutics: A review. J. Contr. Release 2000, 65, 271-284.
15. Arun, K.I.; Khaled, G.; Fang, J.; Maeda, H. Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov. Today 2006, 11, 812-818.
16. Cao, N.; Feng, S.S. Doxorubicin conjugated to d-D-tocopheryl polyethylene glycol 1000 succinate (tpgs): Conjugation chemistry, characterization, in vitro and in vivo evaluation. Biomaterials 2008, 29, 3856-3865.
17. Sinha, V.R.; Bansal, K.; Kaushik, R.; Kumria, R.; Trehan, A. Poly-H-caprolactone microspheres and nanospheres: An overview. Int. J. Pharm. 2004, 278, 1-23.
18. Otsuka, H.; Nagasaki, Y.; Kataoka, K. Pegylated nanoparticles for biological and pharmaceutical applications. Adv. Drug Deliv. Rev. 2003, 55, 403-419.
19. Shuai, X.; Merdan, T.; Unger, F.; Wittmar, M.; Kissel, T. Novel biodegradable ternary copolymers hy-pei-g-pcl-b-peg: Synthesis, characterization, and potential as efficient nonviral gene delivery vectors. Macromolecules 2003, 36, 5751-5759.
20. Zahr, A.S.; Davis, C.A.; Pishko, M.V. Macrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol). Langmuir 2006, 22, 8178-8185.
21. Zhang, Y.; Zhuo, R.X. Synthesis and in vitro drug release behavior of amphiphilic triblock copolymer nanoparticles based on poly (ethylene glycol) and polycaprolactone. Biomaterials 2005, 26, 6736-6742.
22. Gong, C.; We, X.; Wang, X.; Wang, Y.; Guo, G.; Mao, Y.; Luo, F.; Qian, Z. Biodegradable self-assembled peg-pcl-peg micelles for hydrophobic honokiol delivery: I. Preparation and characterization. Nanotechnology 2010, 21, 215103.
23. Xu, B.; Yuan, J.; Ding, T.; Gao, Q. Amphiphilic biodegradable poly(ε-caprolactone)-poly(ethyl ene glycol)-poly(ε-caprol actone) triblock copolymers: Synthesis, characterization and their use as drug carriers for foli c acid. Polym. Bull. 2010, 64, 537-551.
24. Ge, H.; Hu, Y.; Jiang, X.; Cheng, D.; Yuan, Y.; Bi, H.; Yang, C. Preparation, characterization, and drug release behaviors of drug nimodipine-loaded poly(Hcaprolactone)-poly(ethylene oxide)-poly(Hcaprolactone) amphiphilic triblock copolymer micelles. J. Pharm. Sci. 2002, 91, 1463-1473.
25. Gou, M.; Zheng, X.; Men, K.; Zhang, J.; Zheng, L.; Wang, X.; Luo, F.; Zhao, Y.; Zhao, X.; Wei, Y.; Qian, Z. Poly(H-caprolactone)/poly(ethylene glycol)/poly(H-caprolactone) nanoparticles: Preparation, characterization, and application in doxorubicin delivery. J. Phys. Chem. B 2009, 113, 12928-12933.
26. Cuong, N.V.; Hsieh, M.F.; Chen, Y.T.; Liau, I. Doxorubicin-loaded nanosized micelles of a star-shaped poly(H-caprolactone)-polyphosphoester block co-polymer for treatment of human breast cancer. J. Biomater. Sci. Polym. Ed. 2010, doi:10.1163/092050610X510533.
27. Cuong, N.V.; Hsieh, M.F.; Chen, Y.T.; Liau, I. Synthesis and characterization of peg-pcl-peg triblock copolymers as carriers of doxorubicin for the treatment of breast cancer. J. Appl. Polym. Sci. 2010, 117, 3694-3703.
28. Eom, H.J.; Choi, J. Oxidative stress of silica nanoparticles in human bronchial epithelial cell, beas-2b. Toxicol. Vitro 2009, 23, 1326-1332.
29. Eliaz, R.E.; Nir, S.; Marty, C.; Szoka, F.C. Determination and modeling of kinetics of cancer cell killing by doxorubicin and doxorubicin encapsulated in targeted liposomes. Cancer Res. 2004, 64, 711-718.
30. Upadhyay, K.K.; Bhatt, A.N.; Mishra, A.K.; Dwarakanath, B.S.; Jain, S.; Schatz, C.; Le Meins, J.-F.; Farooque, A.; Chandraiah, G.; Jain, A.K.; Misra, A.; Lecommandoux, S. The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(J-benzyl l-glutamate)-b-hyaluronan polymersomes. Biomaterials 2010, 31, 2882-2892.
31. Liu, S.Q.; Wiradharma, N.; Gao, S.J.; Tong, Y.W.; Yang, Y.Y. Bio-functional micelles self-assembled from a folate-conjugated block copolymer for targeted intracellular delivery of anti cancer drugs. Biomaterials 2007, 28, 1423-1433.
32. Zhao, H.; Yung, L.Y.L. Selectivity of folate conjugated polymer micelles against different tumor cells. Int. J. Pharm. 2008, 349, 256-268.
33. Nie, S. Understanding and overcoming major barriers in cancer nanomedicine. Nanomedicine 2010, 5, 523-528.
34. Hsieh, M.F.; Cuong, N.V.; Chen, C.H.; Chen, Y.T.; Yeh, J.M. Nano-sized micelles of block copolymers of methoxy poly(ethylene glycol)-poly(H-caprolactone)-graft-2-hydroxyethyl cellulose for doxorubi ci n delivery. J. Nanosci. Nanotechnol. 2008, 8, 2362-2368.
35. Aliabadi, H.M.; Mahmud, A.; Sharifabadi, A.D.; Lavasanifar, A. Micelles of methoxy poly(ethylene oxide)-b-poly(H-caprolactone) as vehicles for the solubilization and controlled delivery of cyclospori ne a. J. Contr. Release 2005, 104, 301-311.
36. Hsieh, M.F.; Lin, T.Y.; Gau, R.J.; Chang, H.T.; Lo, Y.L.; Lai, C.H. Biodegradable polymeric nanoparticles bearing stealth peg shell and lipophilic polyester core. J. Chin. Inst. Chem. Engrs. 2005, 36, 609-615.
37. ASTM F756-00. Standard Practice for Assessment of Hemolytic Properties of Materials; ASTM International: West Conshohocken, PA, USA, 2000; doi:10.1520/F0756-00.
38. Wei, G.; Xiao, S.; Si, D.; Liu, C. Improved hplc method for doxorubicin quantification in rat plasma to study the pharmacokinetics of micelle-encapsulated and liposome-encapsulated doxorubicin formulations. Biomed. Chromatogr. 2008, 22, 1252-1258.